Ultragenyx Pharmaceutical shares owned by D. E. Shaw & Co
Quarter-by-quarter ownership of Ultragenyx Pharmaceutical (RARE) shares owned by D. E. Shaw & Co
from 13F filings
Historical chart of D. E. Shaw & Co investment in Ultragenyx Pharmaceutical
Tip: Access up to 7 years of quarterly data
All positions including Ultragenyx Pharmaceutical held by D. E. Shaw & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Ultragenyx Pharmaceutical by D. E. Shaw & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $7.1M | 238k | 30.08 |
| 2025-06-30 | $20M | 541k | 36.36 |
| 2025-03-31 | $20M | 556k | 36.21 |
| 2024-12-31 | $12M | 286k | 42.07 |
| 2024-09-30 | $15M | 262k | 55.55 |
| 2024-06-30 | $8.4M | 203k | 41.10 |
| 2023-09-30 | $219k | 6.2k | 35.65 |
| 2023-06-30 | $4.4M | 95k | 46.13 |
| 2023-03-31 | $4.8M | 121k | 40.10 |
| 2022-12-31 | $13M | 290k | 46.33 |
| 2022-09-30 | $20M | 472k | 41.41 |
| 2022-06-30 | $21M | 360k | 59.66 |
| 2022-03-31 | $35M | 484k | 72.62 |
| 2021-12-31 | $46M | 547k | 84.09 |
| 2021-09-30 | $43M | 476k | 90.19 |
| 2021-06-30 | $75M | 790k | 95.35 |
| 2021-03-31 | $88M | 775k | 113.86 |
| 2020-12-31 | $102M | 740k | 138.43 |
| 2020-09-30 | $35M | 431k | 82.19 |
| 2020-06-30 | $26M | 337k | 78.22 |
| 2020-03-31 | $18M | 399k | 44.43 |
| 2019-12-31 | $13M | 314k | 42.71 |
| 2019-09-30 | $8.1M | 188k | 42.78 |
| 2019-06-30 | $8.5M | 134k | 63.50 |
| 2019-03-31 | $10M | 144k | 69.36 |
| 2018-12-31 | $14M | 322k | 43.48 |
| 2018-09-30 | $412k | 5.4k | 76.30 |
| 2017-09-30 | $1.2M | 23k | 53.23 |
| 2017-06-30 | $4.8M | 77k | 62.12 |
| 2017-03-31 | $2.6M | 38k | 67.79 |
| 2015-12-31 | $11M | 93k | 112.18 |
| 2015-09-30 | $6.6M | 69k | 96.28 |
| 2015-06-30 | $1.6M | 15k | 102.40 |
| 2015-03-31 | $1.7M | 27k | 62.11 |